China Universal Asset Management Co., Ltd. Crinetics Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 13,364 shares of CRNX stock, worth $590,688. This represents 0.08% of its overall portfolio holdings.
Number of Shares
13,364
Previous 13,364
-0.0%
Holding current value
$590,688
Previous $626,000
0.16%
% of portfolio
0.08%
Previous 0.08%
Shares
12 transactions
Others Institutions Holding CRNX
# of Institutions
221Shares Held
75.8MCall Options Held
631KPut Options Held
749K-
Black Rock Inc. New York, NY5.44MShares$240 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL5.23MShares$231 Million2.68% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.95MShares$219 Million0.59% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.16MShares$184 Million5.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$169 Million0.02% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $2.38B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...